StockDriftsStockDriftsTop 4 Medicxi Ventures Management (Jersey) Ltd Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| CNTA | CENTESSA PHARMACEUTICALS PLC | 80.76% | 19.96M | $792.9M | +0.00%(+0) | $21.01(+88.36%) | 2026-03-31 | |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 8.72% | 2.67M | $85.6M | -6.81%(-195.38K) | $11.08(+240.64%) | 2026-03-31 | |
| PHAT | PHATHOM PHARMACEUTICALS INC | 8.45% | 7.46M | $82.9M | +0.00%(+0) | $15.94(-21.22%) | 2026-03-31 | |
| AURA | AURA BIOSCIENCES INC | 2.07% | 3.04M | $20.3M | +0.00%(+0) | $16.98(-52.77%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +75.39% | +439.55% |
| Top 20 Holdings Unweighted | +63.96% | +340.78% |
Sign up free to track Medicxi Ventures Management (Jersey) Ltd, compare funds side by side, and get alerts the moment positions change.